Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bluebird Bio (NQ: BLUE )

4.635 +0.165 (+3.69%)
Streaming Delayed Price Updated: 1:20 PM EDT, Mar 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,084,905
Open 4.520
Bid (Size) 4.630 (15)
Ask (Size) 4.640 (18)
Prev. Close 4.470
Today's Range 4.480 - 4.670
52wk Range 2.865 - 8.580
Shares Outstanding 67,578,549
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
New branded medicines are coming to market with ever-higher price tags as soon as the first day. Amgen Inc's (NASDAQ: AMGN) lung cancer treatment, Lumakras, carried a hefty price tag of $17,900 per... 
Via Benzinga
Analyst Expectations for bluebird bio's Future
 
Via Benzinga

Performance

YTD
-33.21%
-33.21%
1 Month
-11.04%
-11.04%
3 Month
-35.45%
-35.45%
6 Month
-21.84%
-21.84%
1 Year
-3.64%
-3.64%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
Via Benzinga
1 Beaten-Down Stock That Has a Lot to Prove in 2023
Via The Motley Fool
What 4 Analyst Ratings Have To Say About bluebird bio
Via Benzinga
Why Bluebird Bio (BLUE) Stock Is Getting Hammered
Via Benzinga
Skechers To Rally 40%? Here Are 10 Other Analyst Forecasts For Monday
Via Benzinga
Better Biotech Buy: Bluebird Bio or CRISPR Therapeutics?
Via The Motley Fool
Tesla, Amazon, bluebird, Netflix, Discover Financial: Why These 5 Stocks Are Drawing Investors' Attention Today
Via Benzinga
bluebird bio, Inc. Announces Pricing of $120 Million Public Offering of Common Stock
From bluebird bio, Inc.
Via Business Wire
PNC Financial, bluebird bio And Other Big Stocks Moving Lower On Wednesday
Via Benzinga
Why Is Zomedica (ZOM) Stock Up Today?
Via InvestorPlace
Moderna (MRNA) Stock Pops on RSV Vaccine Trial Results
Via InvestorPlace
Moderna Gets Good News, but Another Biotech Stock Is Falling Again
Via The Motley Fool
Why is Bluebird Bio (BLUE) Stock Down 9% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
bluebird bio, Inc. Announces Proposed Public Offering of Common Stock
From bluebird bio, Inc.
Via Business Wire
bluebird bio Provides Update on Commercial Launch Progress, Program Milestones and 2023 Financial Outlook Ahead of Company Presentation at 41st Annual J.P. Morgan Healthcare Conference
From bluebird bio, Inc.
Via Business Wire
2 Stocks That Could Double Your Money in 2023
Via The Motley Fool
bluebird bio Sells Second Priority Review Voucher for $95 Million
From bluebird bio, Inc.
Via Business Wire
Newly Approved Drugs In US Command Over $200,000 On An Average
Via Benzinga
bluebird bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
From bluebird bio, Inc.
Via Business Wire
bluebird bio Appoints Joseph Vittiglio, JD, as Chief Business and Legal Officer
From bluebird bio, Inc.
Via Business Wire
1 Cathie Wood Stock to Buy While It's Affordable, and 1 to Avoid (for Now)
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.